Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.236EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.153EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.302EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.194EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.308EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.138EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.379EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.240EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.240.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.243EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
R.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.216EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.471EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.420EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
L.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.518EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.551EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.207EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.604EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.111EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.619EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.36.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.36.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.23.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.316EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.436EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.558EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.518EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.368EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.404EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.306EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.328EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.533EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.120.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.528EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.91 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.617EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used